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ABSTRACT
Introduction: In recent years in keeping with
international best practice, clinical guidelines for
common conditions have been developed, endorsed
and disseminated by peak national and professional
bodies. Yet evidence suggests that there remain
considerable gaps between the care that is regarded as
appropriate by such guidelines and the care received
by patients. With an ageing population and increasing
treatment options and expectations, healthcare is likely
to become unaffordable unless more appropriate care
is provided. This paper describes a study protocol that
seeks to determine the percentage of healthcare
encounters in which patients receive appropriate care
for 22 common clinical conditions and the reasons
why variations exist from the perspectives of both
patients and providers.
Methods/design: A random stratiﬁed sample of at
least 1000 eligible participants will be recruited from
a representative cross section of the adult Australian
population. Participants’ medical records from the
years 2009 and 2010 will be audited to assess the
appropriateness of the care received for 22 common
clinical conditions by determining the percentage of
healthcare encounters at which the care provided was
concordant with a set of 522 indicators of care,
developed for these conditions by a panel of 43
disease experts. The knowledge, attitudes and beliefs
of participants and healthcare providers will be
examined through interviews and questionnaires to
understand the factors inﬂuencing variations in care.
Ethics and dissemination: Primary ethics approvals
were sought and obtained from the Hunter New
England Local Health Network. The authors will submit
the results of the study to a relevant journal as well as
undertaking oral presentations to researchers,
clinicians and policymakers.
INTRODUCTION
Australia’s expenditure on healthcare now
exceeds $110b each year, on par with most
developed nations at over 9% of the gross
domestic product.
1 Chronic conditions
comprise a very large proportion of the most
common and costly diseases.
2 Accordingly,
effective prevention and management of
chronic disease is a key policy initiative for all
modern health services.
In theory, evidence-based clinical practice
guidelines allow professionals to integrate
the best available evidence with their clinical
expertise to make informed decisions
regarding individual patient care.
3e8
However, there is mounting evidence that
there are considerable gaps and variations
between the care that is regarded as appro-
priate (in line with evidence-based or at
least consensus-based guidelines) and the
care that is received
9e16 (see box 1). The
RAND study in the USA showed that, on
average, American adults received 55%
of recommended care at the turn of last
century (range 11%e79% for particular
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ARTICLE SUMMARY
Article focus
- What is the percentage of healthcare encounters
at which Australians receive appropriate care?
- What inﬂuences variations in care from the
perspectives of patients and healthcare
providers?
Key messages
- A protocol for a population-based study of
appropriate care of 1000 patients using medical
record review.
Strengths and limitations of this study
- Obtaining a snapshot and using a consistent
method for 522 indicators across 22 common
conditions power diagnostic indicators because
they only present once for each patient.
- The potential attrition rate of healthcare providers
and telephone recruitment of participants may
introduce selection biases.
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13 Since then, progress has been slow for
most conditions, although there have been notable
improvements for certain care indicators, with, for
example, far more patients being discharged on
b blockers after myocardial infarction than previously.
18
In Australia, studies focusing on individual conditions
have shown similar patterns of non-compliance with
indicators. One such study found that patients with
hypertension reached target blood pressures just under
60% of the time and that just over 70% of patients
eligible for screening for hyperlipidaemia were not
screened, screened and found to be hyperlipidaemic but
not treated or treated without reaching target levels
(51%, 12% and 7% of eligible patients, respectively).
10
To meet the needs of an ageing population and
increasing treatment possibilities and expectations,
19
ﬁnancial considerations alone mean that funding must
be diverted from ineffective and non-cost-effective
interventions to more rational appropriate care.
20
However, to do this, we need to understand who is
getting what care from whom, and why, and establish
sustainable methods for the ongoing surveillance of the
appropriateness of care received by patients.
This paper describes the study protocol to undertake
the CareTrack Australia study, one component of
a National Health and Medical Research Council
(NHMRC) program grant 568612
21 on patient safety.
CareTrack Australia has four main aims:
A. to determine the percentage of healthcare encoun-
ters at which Australians receive appropriate care;
B. to determine the percentage of Australians who
receive appropriate care;
C. to identify factors inﬂuencing decisions to depart
from appropriate care, from the perspectives of both
participants and healthcare providers;
D. to make recommendations on what would be neces-
sary to set up sustainable systems for the surveillance
of the appropriateness of healthcare in Australia.
METHODS/DESIGN
The protocol is based on the RAND methodology of
McGlynn et al.
13 We developed an updated set of indi-
cators for a subset of important conditions, will collect
information onsite from healthcare providers and seek
the views of patients and healthcare providers on why
gaps exist in appropriate care. Our study will involve
a retrospective review of the medical records of over
1000 participants over a 2-year period (2009e2010) to
measure compliance with indicators for 22 common
conditions.
There are 13 components to the study protocol of
CareTrack Australia (ﬁgure 1).
Given the scale and complexity of the full study, a small
pilot study was undertaken to determine the types of
problems that might be encountered and to inform the
ﬁnal selection of conditions, their indicators and the
logistical and practical aspects of recruiting participants
and healthcare providers, accessing records and
extracting, recording, storing and analysing the data.
Components 1 and 2: selecting conditions and developing
indicators
Fifty-two candidate conditions were identiﬁed from
published research and disease burden or quality of care
priority lists of seven organisations.
13 22e27 These
conditions were then assessed against the following
criteria:
< the availability of clinical process indicators that were
feasible to collect and had high content and face
validity;
< mainly affecting adults, and with a sufﬁciently high
prevalence to be studied using our methodology
28e30;
< identiﬁed as already being researched at a population
level in Australia.
A ﬁnal set of 22 conditions met these criteria: alcohol
dependence, antibiotic use, asthma, atrial ﬁbrillation,
cerebrovascular accident, chronic heart failure, chronic
obstructive pulmonary disease, community acquired
Box 1 Deﬁnitions used
Condition means acute (eg, myocardial infarction) and
chronic (eg, diabetes) conditions and clinical circumstances
(eg, surgical site infection) or being eligible for screening or
preventive care (eg, mammography).
Evidence-based care (EBC) is the conscientious, explicit
and judicious use of current best evidence in making
decisions about the care of individual patients. The practice
of EBC means integrating individual clinical expertise with
the best available external clinical evidence from systematic
research.
17
Appropriate care for this study is clinical care for a condition
considered to be evidence based or consensus based by
a panel of clinical experts in Australia in the context in which
it was delivered in the years 2009 and 2010.
Indicator is a condition-speciﬁc process measurement of
healthcare management, appropriate for Australian practice
in 2009e2010. Each indicator is scored as to whether
eligible processes for prevention (eg, mammogram), moni-
toring (eg, blood pressure, lipids) or treatment (eg, aspirin,
statins) have been carried out by answering ‘yes’ or ‘no’.
Healthcare provider refers to doctors, nurses, medical
specialists and allied health professionals such as physio-
therapists, occupational therapists and chiropractors.
Healthcare encounter means any consultation with a health-
care provider or attendance at a facility or hospital for an
activity relevant to one of the selected conditions for which
there is an indicator.
Compliance with indicators is expressed as the percentage
of eligible healthcare encounters at which appropriate care
was received. Eligibility or scoring will be determined by the
three criteria listed under Component 2 of the Methods
section.
Participants are patients, clients, consumers or citizens
enrolled in the study who have completed a relevant
interview.
Surveyor is a person with appropriate clinical and audit
experience who has been trained and accredited for the
study to review medical records in relation to the care
indicators.
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CareTrack protocolpneumonia, coronary artery disease, depression, dia-
betes, dyspepsia, hyperlipidaemia, hypertension, low
back pain, obesity, osteoarthritis, osteoporosis, panic
disorder, preventive care, surgical site infection and
venous thromboembolism.
Candidate indicators and guidelines were sourced by
(1) targeting internet sites with existing clinical guide-
lines
13 31e65 and (2) adapting indicators used in the
RAND study.
13 Indicators for each condition were
then collated, grouped into categories (eg, cardiology,
respiratory medicine) and forwarded to clinical experts
for review. Experts were identiﬁed as clinical leaders in
their ﬁeld and typically were employed as the head or
director of a department in a large hospital and/or held
an adjunct academic appointment. They were invited to
score the indicators on a scale of 1e9 for their appro-
priateness (1: not appropriate; 9: very appropriate), in
the context of the care that would be expected to have
been delivered in Australia from 2009 to 2010. A formal
process was employed for managing discrepancies based
on the following criteria: indicators that scored between
7 and 9 by all experts were automatically included;
indicators with scores between 1 and 3 from all experts
were automatically excluded and indicators that scored
Figure 1 The components and
aims of CareTrack Australia.
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CareTrack protocolbetween 4 and 6 or that received scores from each of the
three ranges were subjected to further review, with
further clariﬁcation being sought where required. A
ﬁnal list of 522 indicators was selected by 43 experts to
represent appropriate care for the selected conditions in
the years 2009 and 2010.
To facilitate analysis, indicators were classiﬁed into
three categories:
1. Indicators eligible for scoring at each healthcare
encounter (eg, an exacerbation of asthma) by any
provider (denominator is all eligible encounters).
2. Indicators eligible for scoring at identiﬁed time
intervals by any provider (eg, blood pressure measure-
ments every 6 months) (denominator is a product of
the number of applicable time periods within the 2-
year period of the study and the number of eligible
healthcare providers seen within each time period).
3. Indicators eligible for scoring once for each partici-
pant (eg, indicators to deal with a new diagnosis)
(denominator is 1).
Component 3: securing ethics approvals
Relevant Human Research Ethics Committee (HREC)
approvals were sought and received prior to participant
recruitment and medical record reviews in all jurisdic-
tions, authorities, health services and private hospitals
included in the study.
Component 4: obtaining statutory immunity
Statutory immunity protects from disclosure any identi-
fying information obtained through an approved quality
assurance activity.
66 CareTrack Australia applied to the
Federal (Commonwealth) Minister for Health for statu-
tory immunity under Section VC of the Commonwealth
Health Insurance Act 1973. This was granted on 17
September 2010.
Component 5: determining the sampling strategy
The study aims to access the medical records of 1000
eligible adult participants across South Australia and
New South Wales (as was done in the Quality in
Australian HealthCare Study).
67 The states of New South
Wales and South Australia were chosen because of the
representativeness of populations across urban, regional
and remote regions
68 and offer a suitable range of
demographic characteristics (table 1). Based on a pilot
study of 100 participants, we estimated that 7600
participants would need to be contacted to meet this
target. Half of the participants will be recruited from
each state, and proportional representation from each of
the metropolitan, regional and remote regions will be
targeted, as illustrated in table 1.
The sample will be stratiﬁed by region to obtain
a representative cross section of participants by demo-
graphics and geographic location. One of the four Socio-
Economic Indexes for Areas, the Index of Relative
Socioeconomic Disadvantage (IRSD) will be used to
facilitate comparison of social and economic status
between geographic regions.
70 The IRSD is derived from
multiple-weighted variables such as low income, high
unemployment and low levels of education, which are all
markers of relative socioeconomic disadvantage. Various
combinations of local government areas will be exam-
ined, so that a representative sample can be obtained
with respect to the IRSD index.
Component 6: resolving data management requirements
A web-based tool will be developed to enter data during
medical record review and subsequent data analysis. The
tool will support secure data access, data encryption, off-
line data collection and subsequent database synchro-
nisation (to mitigate against the problems of ﬁre-walls
and poor internet connectivity in various healthcare
settings).
Given the complexity of the indicator set, the tool will
also generate a set of indicators relevant to a particular
condition, based on participant-speciﬁc information.
Indicator algorithms will take into account the type of
healthcare facility or provider, and the participants’
conditions and gender. For example, the database will
automatically ﬁlter out the indicator related to Pap
smears from all male participants.
Component 7: recruiting participants
Participants will be recruited using a two-stage
Computer-Assisted Telephone Interview (CATI) process
(see ﬁgure 2). Interviewers will undergo a training
program prior to recruitment. The ﬁrst stage, CATI 1,
will involve telephoning randomly selected households
from the Telstra White Pages
71 within the selected
subarea and randomly selecting one householder. Once
selected, the householder will be informed of the study
and asked if they would like to receive further informa-
tion. At this time, their demographic details will also be
collected. The CATI 1 interview script is at appendix 1.
People who agree will be sent an information pack that
contains a covering letter, an information sheet and
a consent form that allows CareTrack researchers to
Table 1 Percentage of people living in urban, regional and remote areas of NSW, SA and Australia
68 69
State or territory Metropolitan, % Regional, % Remote or very remote, % Population
NSW 72.6 (2759) 26.8 (1018) 0.6 (23) 7253400
SA 72.7 (2763) 23.5 (893) 3.8 (144) 1647800
Australia 68.4 19.7 2.3 22407700
Numbers in parentheses are numbers of participants to be contacted for recruitment into the study.
NSW, New South Wales; SA, South Australia.
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CareTrack protocolaccess their medical records (appendices 2e4). Receipt
of a participant’s consent marks the start of the second
stage of the recruitment processdCATI 2. Participants
will be re-contacted by telephone to collect details of
their medical conditions that pertain to the study, and
the names and addresses of the healthcare providers
who managed these conditions in 2009 and 2010. The
script for the CATI 2 interview is at appendix 5. Partici-
pants without any of the 22 study conditions or without
a healthcare encounter from 2009 to 2010 or whose only
encounter was day surgery (excluding persons with
dyspepsia who had endoscopy) will be excluded from
further participation at this stage.
Component 8: recruiting healthcare providers
Healthcare providers and/or facilities identiﬁed by
participants will be sent a covering letter, an information
sheet and two consent forms (one for medical record
review and one for an interview) to be completed prior
to a CareTrack surveyor accessing the medical records
(appendices 6e9). Healthcare providers and/or facili-
ties that provide consent will be contacted by CareTrack
Figure 2 The process to recruit
participants and undertake
medical record reviews.
CATI, Computer-Assisted
Telephone Interview.
HCP ¼ Healthcare provider
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CareTrack protocolsurveyors to arrange a suitable time and place to review
the medical records.
Component 9: recruiting and training surveyors
Suitably experienced nurses will be employed to act as
surveyors for the CareTrack study. A key selection crite-
rion will be experience in clinical audit and medical
record review. Six full-time equivalent staff will be
required. The selection process will involve an aptitude
test using an artiﬁcially constructed medical record, with
a requirement to code indicators for certain conditions
under time constraints. A detailed surveyor manual will
outline the conditions, indicators, deﬁnitions, abbrevia-
tions and processes for arranging and conducting
medical record reviews.
Inter-rater reliability will be examined by two methods.
First, all surveyors will code indicators from an artiﬁcial
medical record, which will include all indicators, and
second, dual review of a sample of participants’ records
will be undertaken. For both methods, k scores will be
calculated to test the level of agreement between each
surveyor and one of the researchers (NAH). Based on the
results of the artiﬁcial test, the number of participants’
records to be dual reviewed will be determined at a conﬁ-
dence level of 95%, with a power of 80%. The CareTrack
Australia researchers will provide constant feedback to
surveyors to ensure that they consistently interpret the
medical records according to the CareTrack Australia
deﬁnitions and indicator inclusion and exclusion criteria.
Component 10: reviewing medical records
Surveyors will undertake an explicit criterion-based
medical record review using the data tool (see Compo-
nent 6). Medical record reviews will be conducted for
each participantehealthcare practitioner encounter
(therefore more than one medical record review may be
undertaken for a participant). Surveyors will assess the
medical record for evidence that the participant was
being treated for the condition that they nominated and
for any other of the 22 conditions. The surveyor will
answer each indicator question as ‘Yes’ (care provided
during the encounter was consistent with the indicator),
‘No’ or ‘Not Applicable’ (N/A) (the indicator was not
relevant to the encounter). For example, an answer of
N/A will be assigned to those indicators that relate to
a new diagnosis if the participant already had that
condition. For indicators that are answered N/A or no,
a text ﬁeld will be available for surveyors to explain the
reason for their answer.
Component 11: analysing indicator data
Data storage will be structured to allow identiﬁcation of
indicator categories (see Component 2) and to allow
calculation of compliance of appropriate care by
healthcare encounter (CareTrack aim A) and by partic-
ipant (aim B). Per cent compliance and CIs will be
calculated for each indicator and then aggregated and
reported at the level of condition. Stratiﬁcation will be
undertaken by healthcare provider type.
Component 12: interviewing and surveying participants
This component of the research will identify the main
drivers of participant’s healthcare decision making and
barriers to receiving appropriate care and will aim to
identify if, and how, common ground may be sought
between patients and providers in providing appropriate
care. Semistructured interviews and self-administered
questionnaires of participants will be used. For selected
common conditions (depression, diabetes, hyper-
lipidaemia, hypertension, low back pain and osteoar-
thritis), participant characteristics (age, sex, occupation
and work history, duration of disease, level of disability
and health literacy) and patient knowledge, attitudes and
beliefs regarding their condition(s) will be examined.
Where possible, for each condition, validated survey tools
will be used. A mixed-methods approach will be used
including quantitative analysis of questionnaires and
qualitative analysis of free-text answers in questionnaires
and transcripts of interviews.
Component 13: interviewing healthcare providers
The knowledge, attitudes and beliefs of healthcare
providers with respect to the treatment and management
of a single condition, osteoarthritis, will be examined.
Osteoarthritis has been chosen because of its high preva-
lence and because of anticipated interactions between
participants and mainstream as well as complementary
and complementary medicine practitioners.
72 Semi-
structured interviews will be conducted at places and times
convenient to healthcare providers. Factors pertaining to
the healthcare providers that will be explored include
socio-demographic characteristics of the provider and the
practice setting, knowledge of clinical indicators for oste-
oarthritis, attitudes to guidelines in general and those
speciﬁcally concerned with osteoarthritis and perceived
barriers to guideline implementation.
CareTrack aim D: developing recommendations for what
would be needed to set up a sustainable system for
surveillance of the appropriateness of care in Australia
A daily lessons log will be kept for the duration of the
study with respect to the barriers encountered for each
component of the study. Strategies actually used and
potential strategies for the future will be identiﬁed, and
a series of recommendations made with respect to how
to establish and maintain a sustainable surveillance
system for appropriateness of care in the future. Details
of the time taken by researchers and surveyors will be
logged to enable various components of the study to be
costed so that priorities can be set, and attention
directed to, the clinical areas that are most problematic.
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